Neutrophil Percentage-to-Albumin Ratio as a Prognostic Marker in Pneumonia Patients Aged 80 and Above in Intensive Care
Neutrophil-Percentage-to-Albumin-Ratio als Prognosemarker bei Pneumoniepatient:innen ab 80 Jahren auf Intensivstation
Journal of Clinical Medicine · 28.04.2025 · 14 (9) · 3033
DOI: 10.3390/jcm14093033 ↗Auf einen Blick
Bei 135 Intensivpatient:innen mit Pneumonie ab 80 Jahren war eine höhere NPAR mit schwererer Erkrankung und höherer Mortalität verbunden. NPAR > 0,286 zeigte ungünstigere klinische Verläufe.
Fragestellung
Hat die Neutrophil-Percentage-to-Albumin-Ratio (NPAR) bei Pneumoniepatient:innen ab 80 Jahren auf Intensivstation prognostischen Wert?
Methode
Retrospektive Auswertung von Intensivpatient:innen mit Pneumonie; Analyse von NPAR, Schweregrad und Mortalität mit Kaplan-Meier-, ROC- und Cox-Regression.
Ergebnisse
135 Patient:innen. NPAR > 0,286 war mit höheren SOFA- und APACHE-II-Scores sowie mehr invasiver Beatmung, Vasopressoren und Sepsis verbunden. NPAR sagte Mortalität unabhängig voraus: HR 2,488 (95 %-KI 1,167–5,302).
Einschränkungen
Retrospektiv; die Autor:innen nennen den Bedarf an großen, multizentrischen, prospektiven Studien zur Bestätigung.
Schlussfolgerung der Autor:innen
NPAR kann laut Autor:innen ein wirksamer Biomarker zur Vorhersage von Krankheits-schwere und Mortalitätsrisiko bei Pneumoniepatient:innen ab 80 Jahren sein.
Kernaussagen
- NPAR > 0,286 war mit höherem SOFA- und APACHE-II-Score verbunden.
- Höhere NPAR ging mit invasiver Beatmung, Vasopressoren und Sepsis einher.
- NPAR war ein unabhängiger Prädiktor der Mortalität: HR 2,488.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 28.04.2025. Verfasst von Maside Ari und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, Ankara Ataturk Sanatorium Training and Research Hospital, 06290 Ankara, Türkiye. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Intensivpflege
Abstract (Originalsprache)
Background/Objectives: In recent years, inflammatory markers have been increasingly utilized to predict disease prognosis. The neutrophil percentage-to-albumin ratio (NPAR) has emerged as a novel biomarker reflecting inflammation and systemic response. This study was conducted to evaluate the prognostic value of NPAR in pneumonia patients aged 80 years and older hospitalized in intensive care.
Methods
Patients aged 80 years and older who were followed up in the intensive care unit with a diagnosis of pneumonia between 1 October 2022, and 31 May 2024, were retrospectively reviewed. Demographic characteristics, laboratory data, disease severity scores (APACHE II, SOFA), intensive care interventions, and variables associated with mortality were analyzed. NPAR was calculated by dividing the neutrophil percentage by the serum albumin level. The prognostic value of NPAR was assessed using Kaplan–Meier survival analysis, receiver operating characteristic (ROC) curve analysis, and Cox regression analysis.
Results
A total of 135 patients were included in the study. Patients with NPAR > 0.286 had significantly higher SOFA (p = 0.002) and APACHE II (p = 0.007) scores. The high NPAR group was at significantly greater risk for requiring invasive mechanical ventilation (p = 0.003), vasopressor support (p = 0.042), and developing sepsis (p = 0.035). Elevated NPAR was strongly associated with mortality (p < 0.001) and was identified as an independent predictor of mortality in the Cox regression analysis (HR = 2.488, 95% CI: 1.167–5.302, p = 0.018).
Conclusions
NPAR may serve as an effective biomarker for predicting disease severity and mortality risk in pneumonia patients aged 80 years and older. Due to its simplicity and accessibility, it can be considered a practical parameter for integration into clinical practice. However, large-scale, multicenter, and prospective studies are needed to validate these findings.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pulmonology, Ankara Ataturk Sanatorium Training and Research Hospital, 06290 Ankara, Türkiye.
- Department of Infectious Diseases and Microbiology, Ankara Etlik City Hospital, 06170 Ankara, Türkiye.
- Department of Pulmonology, Konya Farabi Hospital, 42090 Konya, Türkiye.
- Clinic of Intensive Care Unit, Ankara Gulhane Training and Research Hospital, 06010 Ankara, Türkiye.
- Department of Pulmonology, Ankara University Health Practise and Research Hospitals, 06050 Ankara, Türkiye.
- Department of Pulmonology, Alanya Alaaddin Keykubat University Education and Research Hospital, 07450 Antalya, Türkiye.
ORCID-Profile: Maside Ari, Oral Mentes, Omer Faruk Tuten, Deniz Celik, Melek Doganci, Guler Eraslan Doganay, Emrah Ari
Zitieren
APA
Ari, M., Haykir Solay, A., Ozdemir, T., Yildiz, M., Mentes, O., Tuten, O. F., Tetik Manav, H., Celik, D., Doganci, M., Eraslan Doganay, G., Ari, E., & Usul, E. (2025). Neutrophil Percentage-to-Albumin Ratio as a Prognostic Marker in Pneumonia Patients Aged 80 and Above in Intensive Care. Journal of Clinical Medicine, 14(9), 3033. https://doi.org/10.3390/jcm14093033
Vancouver
Ari M, Haykir Solay A, Ozdemir T, Yildiz M, Mentes O, Tuten OF, et al. Neutrophil Percentage-to-Albumin Ratio as a Prognostic Marker in Pneumonia Patients Aged 80 and Above in Intensive Care. Journal of Clinical Medicine. 2025;14(9):3033. doi:10.3390/jcm14093033
BibTeX
@article{Ari2025,
author = {Ari, Maside and Haykir Solay, Aslı and Ozdemir, Tarkan and Yildiz, Murat and Mentes, Oral and Tuten, Omer Faruk and Tetik Manav, Husra and Celik, Deniz and Doganci, Melek and Eraslan Doganay, Guler and Ari, Emrah and Usul, Eren},
title = {Neutrophil Percentage-to-Albumin Ratio as a Prognostic Marker in Pneumonia Patients Aged 80 and Above in Intensive Care},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {9},
pages = {3033},
doi = {10.3390/jcm14093033}
}
EUVIMED